Literature DB >> 7804012

An improved method for the measurement of total lipid-bound sialic acids after cleavage of alpha 2,8 sialic acid linkage with Vibrio cholerae sialidase in the presence of cholic acid, SDS and Ca2+.

M A Maliakal1, M H Ravindranath, R F Irie, D L Morton.   

Abstract

In the measurement of total lipid-bound sialic acids involving periodic acid oxidation, as in the periodate-resorcinol assay, the inner sialic acids of disialoglycolipids (such as GD3 and GD2) are not involved because their alpha 2,8 ketosidic linkages are resistant to periodic acid oxidation, even after acid/enzyme hydrolysis or alkali pretreatment. However, the sialic acids from these glycolipids can be recovered completely after cleavage of alpha 2,8 linkages by V. cholerae sialidase in the presence of cholic acid, sodium dodecyl sulphate and calcium. Interestingly, removal of calcium or detergent(s) or both significantly minimizes the sialidase action on the disialyl residues of these gangliosides. Therefore, we recommend sialidase (Vibrio cholerae) pretreatment of the glycolipids in the presence of cholic acid, SDS and Ca2+ for complete recovery of sialic acids from di- and polysialogangliosides and for accurate measurement of total lipid-bound sialic acids by periodate-resorcinol assay.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7804012     DOI: 10.1007/bf00731149

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  30 in total

1.  Immunosuppression by human gangliosides. II. Carbohydrate structure and inhibition of human NK activity.

Authors:  G Grayson; S Ladisch
Journal:  Cell Immunol       Date:  1992-01       Impact factor: 4.868

2.  Gangliosides of human melanoma.

Authors:  T Tsuchida; R E Saxton; D L Morton; R F Irie
Journal:  Cancer       Date:  1989-03-15       Impact factor: 6.860

3.  Analysis of sialic acids.

Authors:  R Schauer
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

Review 4.  Gangliosides: structure, isolation, and analysis.

Authors:  R W Ledeen; R K Yu
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

5.  Total and lipid-bound sialic acid levels in sera from patients with cancer.

Authors:  I E Horgan
Journal:  Clin Chim Acta       Date:  1982-02-05       Impact factor: 3.786

6.  Studies on the interaction of Clostridium perfringens sialidase with sialic acid linked to the internal galactose in monosialogangliotetraosyl ceramide.

Authors:  A P Corfield; R Schauer; L Dorland; J F Vliegenthart; H Wiegandt
Journal:  J Biochem       Date:  1985-02       Impact factor: 3.387

7.  Biochemical study on gangliosides in neurofibromas and neurofibrosarcomas of Recklinghausen's disease.

Authors:  T Tsuchida; H Otsuka; M Niimura; Y Inoue; A Kukita; Y Hashimoto; Y Seyama; T Yamakawa
Journal:  J Dermatol       Date:  1984-04       Impact factor: 4.005

8.  Gangliosides of normal and neoplastic human melanocytes.

Authors:  J M Carubia; R K Yu; L J Macala; J M Kirkwood; J M Varga
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

Review 9.  Role of gangliosides in active immunotherapy with melanoma vaccine.

Authors:  M H Ravindranath; D L Morton
Journal:  Int Rev Immunol       Date:  1991       Impact factor: 5.311

10.  Serum sialic acid and CEA concentrations in human breast cancer.

Authors:  A Hogan-Ryan; J J Fennelly; M Jones; B Cantwell; M J Duffy
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.